Patient Selection Bias in Oncology Clinical Trials

Feb 24, 2016

Randomised clinical trials are the gold standard for evaluating new treatments and moreover, they have become part of everyday practice. Many international guidelines recommend RCT at certain stages of oncology diseases. For example, the NCCN guideline for Non-Hodgkin’s lymphoma treatment ...

Read More

Risk Assessment in Clinical Trials

Feb 24, 2016

Risks are an integral part of clinical trials. We routinely come across various risks while managing clinical trials, which are related to quality, safety, timeline, or budget, and they may easily affect the objectives and outcomes of the trials. Risk ...

Read More